CapCut 대안

Forget what's trending. YC's new batch is the new crystal ball for tech. If you didn't know this already, tonight's the deadline for YC for their winter batch, and right now, the fall batch is fully on, so let's see what the future looks like with the fall batches. The current YC batch has hundred and forty-six startups: ninety-six B2B, seventeen consumer, ten healthcare, ten industrial, eight fintech, four real estate, and even one government. And as expected, AI dominates. But you see, here are the three startups that really caught my eye. Number one, Chat AI. This is the world's first brainrot IDE, integrated development environment. It basically allows developers to have integrated environment between the things that you brainrot with, like your TikTok scrolls, your Instagram, anime, whatever it is, into your developer code. How does this work? Instead of having developers fight their urge to brainrot, Chat actually embraces it. So for example, as you're building, AI model is thinking, and you sort of have to wait, and it actually prompts them to go and brainrot. It will show you to your Instagram, your favorite TikToks, so you're actually resting, and then by the time your AI model has loaded, then you're actually back to developing. Number two, Pixley AI. This one's my personal favorite. They're reinventing early education for children. You know when we go into a restaurant, and we see all these iPad kids, and we're like, “Oh my God, they're brain rotting”? Well, this AI tool is about to change it all. This is literally my dream come true. Imagine you draw an image, and then it becomes animation, and then a parent can even put morals or stories that they wanna tell. This makes screen time both educational and also super safe. This is one of the best use cases of video generation that I've seen. Thirdly, Exonic. This is the very first open source drug discovery. I know. When I first read it too, I was like, “What does that even mean?” This company is using AI to design synthetic DNA to help fight cancer. There's a no-code AI solution, and then you submit DNA designs, open source, open to anybody, and the best one gets tested in real cancer cells.